Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax
โ Scribed by Lorraine Tafra; Paul S. Dale; Leslie A. Wanek; Kenneth P. Ramming; Donald L. Morton
- Book ID
- 114060118
- Publisher
- CTSNet
- Year
- 1995
- Tongue
- English
- Weight
- 886 KB
- Volume
- 110
- Category
- Article
- ISSN
- 1097-685X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thirty-one patients with disseminated melanoma or renal cell cancer (RCC) who had a limited relapse or persistent disease after a partial or complete response to interleukin-2 (IL-z)-based immunotherapy underwent resection of progressing tumors or residual sites of disease. There were no surgery-rel
Background. Although a wealth of information is available on adjuvant immunotherapy for melanoma, little is known about adjuvant immunotherapy for head and neck melanoma. Interestingly, a few immunotherapy clinical trials report the observation of clinical responses in a subset of patients with head